Celiac Disease Pipeline Advances with 25+ Therapies; Blood Test Shows Promise for Noninvasive Diagnosis
Over 25 companies are developing 30+ therapies for celiac disease, with recent positive trial results and FDA Fast Track designation. A new blood test using T-cell receptor sequencing may enable noninvasive diagnosis and monitoring.